The Pharmacy Times® Psychedelics Resource Center is a comprehensive resource for clinical news and expert insights on issues related to psychedelic medicine, which includes drugs such as psilocybin, MDMA, LSD, and ketamine, among others. Although not commonly identified as a psychedelic medicine, cannabis can also be included in this category.
May 8th 2024
This is the first FDA advisory committee meeting that will review a potential new posttraumatic stress disorder treatment in 25 years.
Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders
December 11th 2023By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
Read More
Psychedelic Research May Support Unprecedented End-of-Life Care for Patients With Cancer
June 1st 2023Psilocybin and other psychedelics hold promise in treating anxiety, depression, substance abuse and addiction, posttraumatic stress disorder, obsessive compulsive disorder, headaches, and chronic pain disorders.
Read More